JJDC Reportedly in Talks to Acquire Equity Stake in Home Healthcare App Maker CareClic Inc

New Brunswick, NJ - [6 June 2025] - Johnson & Johnson Development Corporation (JJDC), the venture capital subsidiary of Johnson & Johnson, is reportedly in active discussions to acquire an equity stake in CareClic Inc, a fast-rising healthcare technology firm known for its flagship home-care platform, CareClic247.

JJDC, based in New Brunswick, New Jersey, is renowned for investing in transformative healthcare solutions across pharmaceuticals, medical devices, and consumer health. With a long-standing track record of fueling medical innovation, JJDC is said to be eyeing CareClic Inc as a strategic partner in the expanding home healthcare technology space.

Founded in 2017, CareClic Inc has earned a strong reputation for its all-in-one home caregiving platform. The CareClic247 app provides seamless services for medication delivery, real-time health monitoring, and caregiver coordination, making it a vital tool for patients and families seeking quality in-home care.

The potential investment underscores JJDC's interest in digital healthcare platforms that offer scalable, patient-centered solutions-particularly as the demand for remote care and elder services continues to rise.

Media Contact:
Cindy Nguyen
23 Corporate Plaza STE 150, Newport Beach, CA 92660
www.careclic.net
CareClic Inc.

CareClic Inc is a digital health technology company founded in 2017, dedicated to transforming the home healthcare experience through its flagship platform, CareClic247. Designed for patients, caregivers, and healthcare providers, CareClic247 offers a seamless ecosystem for medication delivery, remote health monitoring, and caregiver coordination-all accessible from a single app. With a focus on accessibility, reliability, and personalized care, CareClic empowers families and providers to manage health needs effectively from home.

This release was published on openPR.